This grant, offered by the National Institute on Drug Abuse (NIDA), aims to support small business concerns (SBCs) in continuing research projects focused on robustly validated drug targets for Substance Use Disorders (SUDs). The funding is designed to facilitate the progression of projects through various critical stages of drug discovery and development. This includes initial assay development, lead identification, lead optimization, and preclinical development. The ultimate purpose of this funding opportunity is to enable successful completion of all necessary Investigational New Drug (IND)-enabling activities, moving promising treatments closer to clinical trials for SUDs.
Opportunity ID: 334984
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-22-023 |
| Funding Opportunity Title: | Advancing Validated Drug Targets for Substance Use Disorders (R43/R44 – Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 29, 2021 |
| Last Updated Date: | Jul 29, 2021 |
| Original Closing Date for Applications: | Feb 18, 2022 |
| Current Closing Date for Applications: | Feb 18, 2022 |
| Archive Date: | Mar 26, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications from small business concerns (SBCs) to continue research projects with robustly validated targets for Substance Use Disorders (SUDs). This FOA will provide funding for projects entering at either assay development (AD), lead identification (LI), lead optimization (LO), or preclinical development (PCD) stages to allow for the ultimate goal of successfully completing Investigational New Drug-enabling activities. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-023.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 334984 Full Announcement-RFA-DA-22-023 -> RFA-DA-22-023-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270956 | Jan 18, 2022 | Feb 18, 2022 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268372 | Jan 18, 2022 | Jan 24, 2022 | View |
Package 1
Mandatory forms
334984 RR_SF424_5_0-5.0.pdf
334984 PHS398_CoverPageSupplement_5_0-5.0.pdf
334984 RR_OtherProjectInfo_1_4-1.4.pdf
334984 PerformanceSite_4_0-4.0.pdf
334984 RR_KeyPersonExpanded_4_0-4.0.pdf
334984 RR_Budget_3_0-3.0.pdf
334984 PHS398_ResearchPlan_4_0-4.0.pdf
334984 SBIR_STTR_Information_3_0-3.0.pdf
334984 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334984 RR_SubawardBudget30_3_0-3.0.pdf
334984 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
334984 RR_SF424_2_0-2.0.pdf
334984 PHS398_CoverPageSupplement_5_0-5.0.pdf
334984 RR_OtherProjectInfo_1_4-1.4.pdf
334984 PerformanceSite_2_0-2.0.pdf
334984 RR_KeyPersonExpanded_2_0-2.0.pdf
334984 RR_Budget_1_4-1.4.pdf
334984 PHS398_ResearchPlan_4_0-4.0.pdf
334984 SBIR_STTR_Information_1_3-1.3.pdf
334984 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334984 RR_SubawardBudget30_1_4-1.4.pdf
334984 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
